Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite

Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

By Masuda Hiroko   Masuda Norikazu   Kodama Yoshinori   Ogawa Masami   Karita Michiko   Yamamura Jun   Tsukuda Kazunori   Doihara Hiroyoshi   Miyoshi Shinichiro   Mano Masayuki   Nakamori Shoji   Tsujinaka Toshimasa  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 911-917

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of neoadjuvant chemotherapy for triple-negative breast cancer: a meta-analysis with 723 cases

By Zhang Guojing   Xie Wanqing   Xu Long   Liu Zhaozhe   Xie Xiaodong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 15-19

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer

By                  

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1209-1212

Spandidos Publications

Access to resources Recommend Favorite